Article Text
Statistics from Altmetric.com
We read the article ‘'N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis (IP): results from the Norfolk Arthritis Registry (NOAR)’’ by Mirjafari et al1 with interest. The authors aimed to measure serum NT-pro-BNP levels in a large, well-characterised inception cohort of patients with early IP and examine baseline association of NT-pro-BNP levels with IP disease phenotype, clinical cardiovascular disease (CVD) risk markers and subclinical atherosclerosis surrogates. They concluded that in early IP patients, elevated NT-pro-BNP is related to Health Assessment Questionnaire …
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.